SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $524,629 | -67.6% | 19,029 | -64.7% | 0.00% | -100.0% |
| Q2 2023 | $1,620,625 | +12.9% | 53,913 | +36.0% | 0.00% | 0.0% |
| Q1 2023 | $1,435,976 | +43.5% | 39,635 | +41.2% | 0.00% | – |
| Q4 2022 | $1,000,971 | +291.0% | 28,062 | +271.9% | 0.00% | – |
| Q3 2022 | $256,000 | +468.9% | 7,545 | +376.3% | 0.00% | – |
| Q2 2022 | $45,000 | -98.3% | 1,584 | -98.1% | 0.00% | -100.0% |
| Q1 2022 | $2,707,000 | -6.2% | 83,764 | -15.4% | 0.00% | 0.0% |
| Q4 2021 | $2,886,000 | +3463.0% | 98,999 | +3148.0% | 0.00% | – |
| Q3 2021 | $81,000 | -89.1% | 3,048 | -87.4% | 0.00% | – |
| Q2 2021 | $744,000 | -83.8% | 24,143 | -86.2% | 0.00% | -100.0% |
| Q1 2021 | $4,585,000 | +0.5% | 175,149 | -3.4% | 0.00% | 0.0% |
| Q4 2020 | $4,564,000 | +1204.0% | 181,382 | +981.6% | 0.00% | – |
| Q3 2020 | $350,000 | -50.4% | 16,770 | -43.6% | 0.00% | – |
| Q2 2020 | $706,000 | -3.8% | 29,717 | -27.2% | 0.00% | – |
| Q1 2020 | $734,000 | -42.3% | 40,828 | -23.8% | 0.00% | – |
| Q4 2019 | $1,271,000 | -71.7% | 53,575 | -67.2% | 0.00% | -100.0% |
| Q3 2019 | $4,485,000 | -80.5% | 163,200 | -76.6% | 0.00% | -88.9% |
| Q2 2019 | $23,040,000 | -2.8% | 696,262 | +2.9% | 0.01% | -10.0% |
| Q1 2019 | $23,699,000 | +103.3% | 676,351 | +92.8% | 0.01% | +100.0% |
| Q4 2018 | $11,656,000 | -28.3% | 350,883 | +8.7% | 0.01% | -16.7% |
| Q3 2018 | $16,250,000 | +816.5% | 322,740 | +989.6% | 0.01% | +500.0% |
| Q2 2018 | $1,773,000 | +169.9% | 29,620 | +106.5% | 0.00% | – |
| Q1 2018 | $657,000 | +20.3% | 14,346 | +4.7% | 0.00% | – |
| Q4 2017 | $546,000 | -69.3% | 13,705 | -69.2% | 0.00% | -100.0% |
| Q3 2017 | $1,781,000 | -31.8% | 44,522 | -26.5% | 0.00% | 0.0% |
| Q2 2017 | $2,611,000 | +37.3% | 60,582 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $1,902,000 | +276.6% | 60,740 | +203.5% | 0.00% | – |
| Q4 2016 | $505,000 | -26.2% | 20,011 | -27.7% | 0.00% | – |
| Q3 2016 | $684,000 | +643.5% | 27,689 | +513.4% | 0.00% | – |
| Q2 2016 | $92,000 | +35.3% | 4,514 | +0.7% | 0.00% | – |
| Q1 2016 | $68,000 | -90.3% | 4,482 | -91.4% | 0.00% | – |
| Q4 2015 | $698,000 | -1.0% | 51,930 | +3.4% | 0.00% | – |
| Q3 2015 | $705,000 | -11.7% | 50,229 | +6.8% | 0.00% | -100.0% |
| Q2 2015 | $798,000 | +47.8% | 47,017 | +5.4% | 0.00% | – |
| Q1 2015 | $540,000 | +95.7% | 44,624 | +34.6% | 0.00% | – |
| Q4 2014 | $276,000 | – | 33,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |